Susquehanna International Group, LLP Paratek Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.52 - $2.8 $64,423 - $118,675	42,384 Added 56.03%	118,025 $260,000
Q1 2023 May 16, 2023	BUY	$1.37 - $2.54 $40,872 - $75,778	29,834 Added 65.13%	75,641 $192,000
Q4 2022 Feb 14, 2023	SELL	$1.67 - $2.51 $22,631 - $34,015	-13,552 Reduced 22.83%	45,807 $85,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $2.93 $162,729 - $243,263	-83,025 Reduced 58.31%	59,359 $153,000
Q2 2022 Aug 15, 2022	BUY	$1.73 - $3.09 $158,893 - $283,804	91,846 Added 181.74%	142,384 $275,000
Q1 2022 May 16, 2022	SELL	$2.94 - $4.77 $380,265 - $616,961	-129,342 Reduced 71.9%	50,538 $150,000
Q4 2021 Feb 14, 2022	BUY	$4.07 - $5.3 $64,354 - $83,803	15,812 Added 9.64%	179,880 $808,000
Q3 2021 Nov 15, 2021	BUY	$4.7 - $7.24 $147,232 - $226,800	31,326 Added 23.6%	164,068 $797,000
Q2 2021 Aug 11, 2021	BUY	$6.81 - $10.93 $549,199 - $881,460	80,646 Added 154.8%	132,742 $905,000
Q1 2021 May 17, 2021	BUY	$6.14 - $8.31 $244,077 - $330,339	39,752 Added 322.03%	52,096 $368,000
Q4 2020 Feb 16, 2021	SELL	$4.58 - $7.14 $296,225 - $461,800	-64,678 Reduced 83.97%	12,344 $77,000
Q3 2020 Nov 16, 2020	BUY	$4.19 - $6.69 $271,775 - $433,933	64,863 Added 533.46%	77,022 $417,000
Q2 2020 Aug 14, 2020	SELL	$2.97 - $5.22 $107,362 - $188,697	-36,149 Reduced 74.83%	12,159 $63,000
Q1 2020 May 15, 2020	SELL	$2.67 - $4.97 $307,907 - $573,145	-115,321 Reduced 70.48%	48,308 $152,000
Q4 2019 Feb 14, 2020	BUY	$2.93 - $4.5 $158,263 - $243,067	54,015 Added 49.28%	163,629 $659,000
Q3 2019 Nov 14, 2019	BUY	$3.08 - $5.76 $238,866 - $446,711	77,554 Added 241.9%	109,614 $474,000
Q2 2019 Aug 16, 2019	BUY	$3.47 - $6.32 $25,337 - $46,148	7,302 Added 29.49%	32,060 $128,000
Q2 2019 Aug 14, 2019	SELL	$3.47 - $6.32 $1,703 - $3,103	-491 Reduced 1.94%	24,758 $99,000
Q4 2018 Feb 14, 2019	SELL	$4.8 - $11.6 $663,652 - $1.6 Million	-138,261 Reduced 84.56%	25,249 $130,000
Q3 2018 Nov 14, 2018	BUY	$9.05 - $10.95 $976,531 - $1.18 Million	107,904 Added 194.05%	163,510 $1.59 Million
Q2 2018 Aug 14, 2018	SELL	$10.2 - $13.9 $53,641 - $73,100	-5,259 Reduced 8.64%	55,606 $567,000
Q1 2018 May 15, 2018	SELL	$12.65 - $18.85 $812,509 - $1.21 Million	-64,230 Reduced 51.34%	60,865 $791,000
Q4 2017 Feb 14, 2018	BUY	$17.45 - $25.6 $1.68 Million - $2.46 Million	96,086 Added 331.23%	125,095 $2.24 Million
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $548,270 - $818,053	29,009	29,009 $728,000

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account